MA
AMPE

Montag & Associates’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Montag & Associates’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-767
Closed -$129K – 318
2019
Q1 		$129K Hold
767
– – 0.01% 301
2018
Q4 		$91K Buy
767
+617
+411% +$94.7K 0.01% 282
2018
Q3 		$23K Buy
150
+67
+81% +$28K ﹤0.01% 318
2018
Q2 		$55K Buy
+83
New +$62.1K 0.01% 277

Other funds holding AMPE

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Montag & Associates's AMPE Position: Q2 2019 in Review

Montag & Associates sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2019, closing a stake of 767 shares — an estimated $129K sold.

Montag & Associates first reported a position in AMPE in Q2 2018 and held it in 4 quarters. The position peaked at $129K in Q1 2019. 81 funds tracked by Wall St. Rank hold AMPE as of Q2 2019.

  • Montag & Associates reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Montag & Associates sold 767 Ampio Pharmaceuticals Inc. shares in Q2 2019, an estimated $129K.
  • Montag & Associates first reported a position in Ampio Pharmaceuticals Inc. in Q2 2018 and held it in 4 quarters.
  • Montag & Associates's Ampio Pharmaceuticals Inc. position peaked at $129K in Q1 2019.
  • 81 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2019.

Based on Montag & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.